Tuesday, April 24, 2012

Novartis Pushes UK Hospitals to Use $1,000 Drug - Apr. 24, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Tuesday, April 24, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Introducing OncologyMAP® v2.0, Myriad RBM's powerful new service that quantitatively measures 130 cancer-related proteins.

Please click here for more information.
HeadHtml
•  Novartis AG (NVS) Pushes UK Hospitals to Use $1,000 Drug More...
•  Affymax, Inc. (AFFY) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Release: OMONTYS® (Peginesatide) Injection Now Available for Adult Chronic Kidney Disease (CKD) Patients on Dialysis in the United States More...
•  Mylan Inc. (MYL) Launches Generic Version of Zyprexa® Tablets More...
•  Vertex Pharmaceuticals (MA) (VRTX) Release: INCIVEK™ (telaprevir) Now Funded for People With Hepatitis C in Quebec and Saskatchewan More...
•  Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Olanzapine Tablets More...
More Drug Product News
HeadHtml
•  Ikaria Inc.'s LUCASSIN® Approved in Australia More...
More Drug Approval News
HeadHtml
•  Alimera Sciences (ALIM) Release: ILUVIEN® Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema More...
More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Biogen Idec, Inc. (Massachusetts) (BIIB) Says Phase III Data Highlight Safety Profile For BG-12 MS Drug; Stock Rises +Up 2.14(1.70%) @ 1:22PM EDT More...
•  Sosei Group Corporation's QVA149 ILLUMINATE Phase III COPD Study Meets Primary Endpoint and Clarification of Anticipated Timing of US Filings for NVA237 and QVA149 More...
•  Nordion International Announces Europe-Focused Phase III Clinical Trial for TheraSphere® Liver Cancer Treatment More...
•  RedHill Biopharma Ltd. Commences a Pivotal Bioequivalence Trial with RHB-103 (An Oral Thin Film for the Treatment of Migraine); Subjects' Recruitment Completed; First Dose Administered; Results Expected within Months More...
•  Coronado Biosciences Announces Independent Data Monitoring Committee Recommendation to Continue Falk Phase 2 Trial of TSO in Crohn's Disease More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
HeadHtml
•  Evidence Behind Autism Drugs May Be Biased, University of Michigan Study More...
•  Could Caffeine Help Dry Eye? University of Tokyo School of Medicine Study More...
•  How to Look Good on Facebook, University of Twente Study More...
•  PURE Bioscience (PURE) Announces Positive Research from University of Arkansas More...
•  Advanced Cell Technology Announces Data and Safety Monitoring Board (DSMB) Approval to Increase RPE Dosage for Stargardt's Disease Patients in U.S. Trial More...
More General Clinical Research News
Events

The Biomarker World Congress 2012 is dedicated to all areas of biomarker research. The meeting brings together a mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers.

For more information visit: www.BiomarkerWorldCongress.com.
Latest Market Insight

Biomarkers in Late Stage Clinical Trials

• Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World.
• Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies.
• Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis.

Click Here for More Information.
Tower: Facebook
Top Jobs
BioMidwest (Chicago, Illinois)

Takeda Pharmaceuticals
Associate Trial Manager, Phase 1 Operations
Responsible for the execution of Phase 1 clinical studies according to ICH, GCP guideline, and required regional regulations as applicable in support of the clinical strategies defined in the Integrated Development Plan (IDP)

Rocky Bio (Phoenix, Arizona)

Roche Diagnostics
Clinical Specialist
Will support all aspects of clinically focused sales for Roche's ACCU-CHEK product line, which includes blood glucose meters, insulin delivery systems, diabetes information management solutions, diabetes programs and services, and co-promoted product solutions within an assigned territory.

Pharm Country (Kinnelon, New Jersey)

ClinAudits
Manager Clinical GCP Compliance Operations
Overseeing administrative and support functions such as continued communication with field auditors, employees, vendors and clients; scheduling and ensuring timely progress of workflow; managing databases; improving and enhancing workflow processes; and being a key part of the decision-making process.

Biotech Bay (Mountain View, California)

MedImmune, LLC
Associate Project Manager, Clinical Sample & Data Management
Represents CS&DM on Clinical Project Teams and applicable sub-teams for assigned ongoing and upcoming clinical studies of varying complexity across Therapeutic Areas. Plan and coordinate CS&DM activities in support of pre-clinical and clinical trials.

Biotech Beach (Irvine, California)

Allergan Inc.
Senior Manager, Clinical Quality
Design and oversee delivery of quality training programs to Global Development staff for controlled procedural and processes training. Design, lead and manage the development, maintenance, and delivery of Global Development training consistent with regional and global CFR / ICH GCP / ISO regulatory requirements.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Pharm Country

BioCapital Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Mid-Atlantic region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  NewLink Genetics Receives Notice of Allowance From USPTO for New Patent Broadly Covering Its D-1MT IDO Pathway Inhibitor More...
•  MediciNova, Inc. Receives Notice of an Australian Patent Allowance for a Method of Treating Neuropathic Pain More...
More Patent News
Feature

Hot Company

Genentech (Oceanside)
One Antibody Way
Oceanside, California 92056 U.S.A.
Phone: 760-231-2440

Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego. Today, the campus spans 60 acres and includes a multi-product, biotech manufacturing and clinical operations complex with six buildings totaling 500,000 square feet.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: